![]()
|
|
||||||||
J. Biol. Chem., Vol. 278, Issue 18, 15550-15557, May 2, 2003
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the The PXIXIT
calcineurin binding motif or highly related sequences are found in a
variety of calcineurin-binding proteins in yeast, mammalian cells, and
viruses. The accessory protein p12I encoded in the HTLV-1
pX ORF I promotes T cell activation during the early stages of HTLV-1
infection by activating nuclear factor of activated T cells (NFAT)
through calcium release from the endoplasmic reticulum. We identified
in p12I, a conserved motif, which is highly homologous with
the PXIXIT calcineurin-binding motif of NFAT.
Both immunoprecipitation and calmodulin agarose bead pull-down assays
indicated that wild type p12I and mutants of
p12I that contained the motif-bound calcineurin. In
addition, an alanine substitution p12I mutant
(p12I AXAXAA) had greatly reduced
binding affinity for calcineurin. We then tested whether
p12I binding to calcineurin affected NFAT activity.
p12I competed with NFAT for calcineurin binding in
calmodulin bead pull-down experiments. Furthermore, the
p12I AXAXAA mutant enhanced NFAT
nuclear translocation compared with wild type p12I and
increased NFAT transcriptional activity 2-fold greater than wild type
p12I. Similar to NFAT, endogenous calcineurin phosphatase
activity was increased in Jurkat T cells expressing p12I
independent of its calcineurin binding property. Thus, the reduced binding of p12I to calcineurin allows enhanced nuclear
translocation and transcription mediated by NFAT. Herein, we are the
first to identify a retroviral protein that binds calcineurin. Our data
suggest that HTLV-1 p12I modulates NFAT activation to
promote early virus infection of T lymphocytes, providing a novel
mechanism for retrovirus-mediated cell activation.
A Conserved Calcineurin-binding Motif in Human T Lymphotropic
Virus Type 1 p12I Functions to Modulate Nuclear Factor of
Activated T Cell Activation*
,
,
§,
¶
, and
¶
**
Center for Retrovirus Research and
Department of Veterinary Biosciences, ¶ Comprehensive Cancer
Center, The Arthur G. James Cancer Hospital and Solove Research
Institute, and the
Department of Molecular Virology, Immunology,
and Medical Genetics, Ohio State University,
Columbus, Ohio 43210-1093
*
This work was supported by National Institutes of Health
Grants RR-14324, AI-01474, and CA-92009 (to M. D. L.) and NCI,
National Institutes of Health, Grant CA-70529 (to the Ohio State
University Comprehensive Cancer Center).The costs of publication of this article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
K. R. Jerome Viral Modulation of T-Cell Receptor Signaling J. Virol., May 1, 2008; 82(9): 4194 - 4204. [Full Text] [PDF] |
||||
![]() |
R. Fukumoto, M. Dundr, C. Nicot, A. Adams, V. W. Valeri, L. E. Samelson, and G. Franchini Inhibition of T-Cell Receptor Signal Transduction and Viral Expression by the Linker for Activation of T Cells-Interacting p12I Protein of Human T-Cell Leukemia/Lymphoma Virus Type 1 J. Virol., September 1, 2007; 81(17): 9088 - 9099. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Miyazaki, J.-I. Yasunaga, Y. Taniguchi, S. Tamiya, T. Nakahata, and M. Matsuoka Preferential Selection of Human T-Cell Leukemia Virus Type 1 Provirus Lacking the 5' Long Terminal Repeat during Oncogenesis J. Virol., June 1, 2007; 81(11): 5714 - 5723. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Czirjak and P. Enyedi Targeting of Calcineurin to an NFAT-like Docking Site Is Required for the Calcium-dependent Activation of the Background K+ Channel, TRESK J. Biol. Chem., May 26, 2006; 281(21): 14677 - 14682. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Puri, B. S. Magenheimer, R. L. Maser, E. M. Ryan, C. A. Zien, D. D. Walker, D. P. Wallace, S. J. Hempson, and J. P. Calvet Polycystin-1 Activates the Calcineurin/NFAT (Nuclear Factor of Activated T-cells) Signaling Pathway J. Biol. Chem., December 31, 2004; 279(53): 55455 - 55464. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Waldele, G. Schneider, T. Ruckes, and R. Grassmann Interleukin-13 Overexpression by Tax Transactivation: a Potential Autocrine Stimulus in Human T-Cell Leukemia Virus-Infected Lymphocytes J. Virol., June 15, 2004; 78(12): 6081 - 6090. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. R. Silverman, A. J. Phipps, A. Montgomery, L. Ratner, and M. D. Lairmore Human T-Cell Lymphotropic Virus Type 1 Open Reading Frame II-Encoded p30II Is Required for In Vivo Replication: Evidence of In Vivo Reversion J. Virol., April 15, 2004; 78(8): 3837 - 3845. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ding, S.-J. Kim, A. M. Nair, B. Michael, K. Boris-Lawrie, A. Tripp, G. Feuer, and M. D. Lairmore Human T-Cell Lymphotropic Virus Type 1 p12I Enhances Interleukin-2 Production during T-Cell Activation J. Virol., October 15, 2003; 77(20): 11027 - 11039. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |